StockData
Connect Biopharma Holdings Ltd logo

Connect Biopharma Holdings Ltd (CNTB) stock

CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.58−0.06 (-9.98%)

Close on Nov 17, 2026Market cap $36.45MP/E –Yield –

Connect Biopharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Connect Biopharma's enterprise value was $11.88M on Nov 11, 2026, against $101.96M a year earlier. Over the last 5 years it ranged from -$223.65M to $110.12M, with a median of -$25.56M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$11.88M-88.4%
2025Dec 31, 2025$102.52M–
2024Dec 31, 2024-$33.59M–
2023Dec 29, 2023-$16.62M–
2022Dec 30, 2022-$93.62M–
2021Dec 31, 2021-$66.79M–

More Connect Biopharma figures

See a number that looks wrong?